A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

NCT02395042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystitis, Interstitial
Ulcer

Interventions

DRUG: LiRIS®
DRUG: LiRIS Placebo

Sponsor

Allergan